|
GRFS
|
Grifols, S.A.
|
4.26%
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
4.15%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
4.06%
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
3.76%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
3.64%
|
US
|
NASDAQ
|
|
MTD
|
Mettler-Toledo International, Inc.
|
3.57%
|
US
|
NYSE
|
|
ALKS
|
Alkermes plc
|
3.52%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
3.51%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
3.49%
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
3.49%
|
US
|
NASDAQ
|
|
QGEN
|
Qiagen N.V.
|
3.43%
|
US
|
NYSE
|
|
TECH
|
Techne Corporation
|
3.37%
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
3.36%
|
US
|
NASDAQ
|
|
IQV
|
IQVIA Holdings, Inc.
|
3.33%
|
US
|
NYSE
|
|
INCY
|
Incyte Corporation
|
3.31%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
3.30%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
3.27%
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
3.21%
|
US
|
NASDAQ
|
|
CRL
|
Charles River Laboratories International, Inc.
|
3.18%
|
US
|
NYSE
|
|
AMGN
|
Amgen Inc.
|
3.16%
|
US
|
NASDAQ
|